Litcius/Paper detail

ZFHX3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancer

Jiexia Zhang, Ningning Zhou, Anqi Lin, Peng Luo, Xin Chen, Huojin Deng, Shijun Kang, Linlang Guo, Weiliang Zhu, Jian Zhang

2020Cancer Immunology Immunotherapy140 citationsDOIOpen Access PDF

Topics & Concepts

ImmunotherapyMedicineOncologyBiomarkerLung cancerInternal medicineImmune systemCohortCancer researchImmunologyCancerBiologyGeneticsCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosisLung Cancer Treatments and Mutations
ZFHX3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancer | Litcius